Skip to content

Real-World Evaluation of the Therapeutic Effect of "Si Gen Jiang Zhi Decoction" on Dyslipidemia in Breast Cancer Based on the HIS System

Real-World Evaluation of the Therapeutic Effect of "Si Gen Jiang Zhi Decoction" on Dyslipidemia in Breast Cancer Based on the HIS System

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001367
Enrollment
Unknown
Registered
2025-07-09
Start date
2025-05-11
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant tumor of breast

Interventions

exposure group:Take "Si Gen Jiang Zhi Decoction" for at least 1 course of treatment or plan to take, i.e. 84 doses
control group:Those who have not received traditional Chinese medicine treatment of "Si Gen Jiang Zhi Decoction" within 3 months, and have no intention of "sigen Jiangzhi Decoction" treatment.

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Exposure group: 1) Female aged = 18 and = 80 years; 2) Early breast cancer patients who completed standard malignant tumor treatment; 3) Those who have been prescribed a course of "Si Gen Jiang Zhi Decoction" in the breast clinic of our hospital (i.e. 3 months) or plan to take a course of "Si Gen Jiang Zhi Decoction" after communicating with the doctor; 4) Those who understand and agree to participate in this study and sign the informed consent. Control group: 1) Female aged = 18 and = 80 years; 2) Early breast cancer patients who completed standard malignant tumor treatment; 3) Those who have not taken "Si Gen Jiang Zhi Decoction" or other traditional Chinese medicine or Chinese patent medicine within 3 months; 4) Those who understand and agree to participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Those who have serious primary diseases such as liver, kidney, blood system or other serious infectious diseases, and the investigator believes that having serious diseases of other systems will affect the judgment of the results of this study; 2) Patients with any other malignant tumor; 3) Pregnant or lactating women; 4) Those who suffer from mental illness, language disorder or are unable to cooperate with the data collector for other reasons; 5) Those who have participated in or are participating in other clinical trials within 1 month before participating in this study.

Design outcomes

Primary

MeasureTime frame
The total effective rate in the evaluation criteria for blood lipid efficacy;

Secondary

MeasureTime frame
Changes in intima-media thickness of carotid artery;Percentage of medication users and duration of medication at each follow-up time point for "Si Gen Jiang Zhi Decoction";Changes in blood glucose related indicators;Incidence of atherosclerotic cardiovascular disease;Medication compliance score for "Si Gen Jiang Zhi Decoction";Changes in the intensity of lipid-lowering drug use;Changes in lifestyle;Changes in liver fat content under liver ultrasound;Changes in Body Mass Index;

Countries

China

Contacts

Public ContactDong Mengting

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine

Nancyd33@163.com13817170419

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026